WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Fennec Pharmaceuticals revenue was $38.79M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $12.5M, up 29.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FENC annual revenue was $47.5M, with 123.7% growth year-over-year.

FENC past revenue growth

How has FENC's revenue growth performed historically?

Company
-21.39%
Industry
284.61%
Market
22.91%
FENC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FENC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

FENC revenue history

Current Revenue
$38.8M
Current Earnings
-$6.9M
Current Profit Margin
-17.9%

Be the first to know when FENC announces revenue.

FENC Revenue History By Year

FENC Yearly RevenueFENC RevenueFENC ChangeFENC Revenue Growth
2024-12-31$47.54M$26.29M+123.69%
2023-12-31$21.25M$19.72M+1,284.50%
2022-12-31$1.54MN/AN/A
2021-12-31$0.00-$170.00k-100.00%
2020-12-31$170.00kN/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-12-31$0.00N/AN/A
2008-12-31$0.00N/AN/A
2007-12-31$0.00N/AN/A
2006-12-31$0.00N/AN/A
2005-12-31$0.00N/AN/A
2004-06-30$0.00N/AN/A
2003-06-30$0.00N/AN/A
2002-06-30$0.00N/AN/A

1 of 2

Fennec Pharmaceuticals Revenue FAQ

What was FENC's revenue last quarter?

On Invalid Date, Fennec Pharmaceuticals (NASDAQ: FENC) reported Q3 2025 revenue of $12.46 million up 78.69% year over year. In the same quarter last year, Fennec Pharmaceuticals's revenue was $6.97 million.

What was Fennec Pharmaceuticals's revenue in 2024?

Fennec Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $47.54 million, a 123.69% increase year over year.

How much does Fennec Pharmaceuticals make in a day?

Based on Fennec Pharmaceuticals annual revenue for the past five years, FENC makes an average of $38,627.40 per day.

What was Fennec Pharmaceuticals's annual revenue growth in the past year?

As of Q4 2025, Fennec Pharmaceuticals's revenue has grown -21.39% year over year. This is 306 percentage points lower than the US Biotechnology industry revenue growth rate of 284.61%. Fennec Pharmaceuticals's revenue in the past year totaled $38.79 million.

How much does Fennec Pharmaceuticals make in a year?

Fennec Pharmaceuticals's revenue by year for the past five years is:
  • Fennec Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $47.54 million, a 123.69% increase year over year.
  • Fennec Pharmaceuticals's annual revenue for Dec 31, 2023 was $21.25 million, a 1,284.5% increase from 2022.
  • Fennec Pharmaceuticals's annual revenue for 2022 was $1.54 million, a Infinity% increase from 2021.
  • Fennec Pharmaceuticals's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
  • Fennec Pharmaceuticals's annual revenue for 2020 was $170.00 thousand, a Infinity% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.